COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,250 Articles (22,733 medRxiv, 8,517 bioRxiv)

Most recent first Previous |  Page 467: Articles 4661-4670  | Next

Generation of a SARS-CoV-2 reverse genetics system and novel human lung cell lines that exhibit high virus-induced cytopathology
Khan, J. Q., Rohamare, M., Rajamanickam, K., Bhanumathy, K. K., Lew, J., Kumar, A., Falzarano, D., Vizeacoumar, F., Wilson, J. A.
10.1101/2023.03.08.531833 — Posted: 2023-03-09
Early transcriptional responses of human nasal epithelial cells to infection with Influenza A and SARS-CoV-2 virus differ and are influenced by physiological temperature
Resnick, J. D., Beer, M. A., Pekosz, A.
10.1101/2023.03.07.531609 — Posted: 2023-03-09
COVID-19 as a continuous-time stochastic process
Lone, I., Jan, P. M.
10.1101/2023.03.08.531718 — Posted: 2023-03-09
Inhibition mechanism and antiviral activity of an α-ketoamide based SARS-CoV-2 main protease inhibitor
Chen, X., Huang, X., Ma, Q., Kuzmic, P., Zhou, B., Xu, J., Liu, B., Jiang, H., Zhang, W., Yang, C., Wu, S., Huang, J., Li, H., Long, C., Zhao, X., Xu, H., Sheng, Y., Guo, Y., Niu, C., Xue, L., Xu, Y., Liu, J., Zhang, T., Spencer, J., Deng, W., Chen, S.-H., Xiong, X., Yang, Z., Zhong, N.
10.1101/2023.03.09.531862 — Posted: 2023-03-09
Assessment of the Performance of Expired and Unexpired BinaxNOW COVID Rapid Antigen Test Kits Using Positive and Negative Controls
Vaeth, M. J., Mitchell, A., Sun, K. J., Foyez, M., Byrd, L., Elhabashy, M., Cheema, M., Gupta, I., Purekal, S., Locke, C., Kantsiper, M., Siddiqui, Z. K.
10.1101/2023.03.01.23286637 — Posted: 2023-03-09
The impact of public-initiated COVID-19 risk communication on individual NPI practices
Zele, Y. T., Kumie, A., Hailemariam, D., Wakuma, S., Abegaz, T., Yirsaw, S.
10.1101/2023.03.07.23286938 — Posted: 2023-03-08
Excess Mortality in the Vaccination Era in the United States, By State and 6-Month Period
Faust, J. S., Renton, B., Du, C., Chen, A. J., Li, S.-X., Lin, Z., Krumholz, H. M.
10.1101/2023.03.07.23286927 — Posted: 2023-03-08
Forecasting the trajectory of the COVID-19 pandemic into 2023 under plausible variant and intervention scenarios: a global modelling study
Reiner, R., Collins, J. K., COVID-19 Forecasting Team, , Murray, C. J. L.
10.1101/2023.03.07.23286952 — Posted: 2023-03-08
State-Level Excess Mortality in US Adults During the Delta and Omicron Waves of COVID-19
Renton, B., Du, C., Chen, A. J., Li, S.-X., Lin, Z., Krumholz, H. M., Faust, J. S.
10.1101/2023.03.07.23286933 — Posted: 2023-03-08
The external validity of machine learning-based prediction scores from hematological parameters of COVID-19: A study using hospital records from Brazil, Italy, and Western Europe
Bandyopadhyay, D.
10.1101/2023.03.07.23286949 — Posted: 2023-03-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).